Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 11, 376 - 377 (2005)
doi:10.1038/nm0405-376
MET orchestrates cancer and blood coagulation
Olga I Stenina1 & Edward F Plow1
- The authors are in the Department of Molecular Cardiology, the Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. e-mail: plowe@ccf.org
Abstract
A new mouse model begins to unravel a longstanding mystery: why are cancers often associated with blood coagulation disorders?
The close interconnection between cancer and thrombosis, often referred to as Trousseau syndrome, was first appreciated almost one and a half centuries ago1, and has been widely documented in the basic and clinical literature. Indeed, markers of a perturbed coagulation system are often used as diagnostic and prognostic indicators of malignancy.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Keeping blood clots at bay in sepsisNature Medicine News and Views (01 Jun 2008)
Thrombi?beware of red cells bearing giftsNature Biotechnology News and Views (01 Aug 2003)
RESEARCH
Biological Action of Ultra-Violet RaysNature Research Article (21 Apr 1928)
The MET oncogene drives a genetic programme linking cancer to haemostasisNature Letters to Editor (17 Mar 2005)
